期刊文献+

二溴青酶烷砜酸还原制备舒巴坦工艺方法的研究

Technical i nvestigation on the synthesis of sul bactam by debrominating di bromosul bacta m acid
下载PDF
导出
摘要 对舒巴坦合成的脱溴还原工艺过程进行了方法选择和优化研究,并分别对以锌、镁为还原剂工艺和以雷尼镍、钯碳为催化剂的氢气还原工艺进行了比较,得出以钯碳为催化剂,在0.2 MPa下,以氢气为还原剂对二溴青酶烷砜酸进行脱溴还原工艺具有比较明显的优势,制得舒巴坦的收率可达到86.5%. In this paper, method and optimization of the debromination-reduction technical process which is the key step in the synthesis of sulbactam with 6-Aminopenicillanic acid material are investigated. Compare with the reductive process when Zn, Mg as reductant and Ni, Pd (C) as catalyst under hydrogen atmosphere respectively, the debromination-reduction technical process provides obvious advantages and the yield of 13-1actamase in- hibitor sulbactam can reach to 86.5% in the present of Pd(C) catalyst and hydrogen at the pressure of 0.2 MPa.
作者 王正平 刘莹
出处 《广州大学学报(自然科学版)》 CAS 2007年第6期37-40,共4页 Journal of Guangzhou University:Natural Science Edition
关键词 舒巴坦 钯碳催化剂 还原 sulbactam Pd (C) catalyst reduction
  • 相关文献

参考文献8

  • 1程宏辉,谢朝晖.舒巴坦钠合成工艺的研究[J].化工设计通讯,2001,27(2):61-62. 被引量:12
  • 2宋智梅,刘巍巍,杨静,孙元珍.舒巴坦的生产工艺改进[J].中国药物化学杂志,2004,14(3):180-181. 被引量:5
  • 3游金莺 欧阳凯.β—内酰胺酶抑制剂—CP45899的工艺研究[J].中国抗生素杂志,1986,11(4):363-365.
  • 4Barth W E. 6-substituted penieillanie acid 1,1-dioxide compounds[ P]. US:d590073,1984-10-22.
  • 5白国义,马桂秋,侯曼玲,李阳,曹琳,王丰雷.β-内酰胺酶抑制剂的研究进展[J].化学工业与工程,2001,18(6):395-400. 被引量:10
  • 6邱方利,潘富友.舒巴坦钠的合成[J].化学世界,2006,47(2):99-101. 被引量:4
  • 7Pfizerlnc. 7-( D-2-[ ethylpierazine-2,3-dione-1 -carbox-amido ] -2-[ 4-hydroxypheny ] acetamido ) -3-( [ 1 -methyl-5-tetrazolyl ] thiomerthyl)-3-deaeetoxymethyleephalosporanie acid and penieillanie acid 1,1-dioxide and pharmaceutical composition containing them [ P]. FR:2442453,1980-06-20.
  • 8Suren husinec, Deana Dragovic. Some approaches to the synthesis of sulbactam[ J]. Cocc Czec Chem Comm, 1989,54:1370- 1375.

二级参考文献16

  • 1张建民,钟超平.泰唑巴坦合成路线图解[J].中国医药工业杂志,1995,26(9):428-429. 被引量:7
  • 2张致平.20世纪90年代β-内酰胺类抗生素研究开发的进展[J].国外医药(抗生素分册),1996,17(1):1-18. 被引量:12
  • 3陈冠荣 时钧 等.化工百科全书,第1版[M].北京:化学工业出版社,1995..
  • 4Shimabayashi Akihiro,et al.Process for producing halogenated beta lactam compound[P].US:6274 730,2001-08-14.
  • 5Volkmann R A,Carroll R D,et al.Synthesis of Penicillamic acid S,S-dioxide[J].J Org Chem,1982,47:3344-3345.
  • 6杨晓 黄斌.青霉烷砜酸的合成[J].南京药学院学报,1985,16(3):35-36.
  • 7United States Pharmacopeial Convention,Inc.United States Pharmacopoeia.Vol.1[M].Board of Trustees Official,2003.1721-1722.
  • 8Pfizer Inc.7-(D-2-[ethylpiperazine-2,3-dione-1-carboxamido]-2-[4-hydroxyphenyl]acetamido)-3-([1-methyl-5-tetrazolyl]thiomethyl)-3-deacetoxymethylcephalosporanic acid and penicillanic acid 1,1-dioxide and pharmaceutical composition containing them[P].FR:24
  • 9Volkmann RA,Moore BS,Carroll RD,et al.Efficient preparation of 6,6-dihalopenicillanic acids,synthesis of penicillanic acid S,S-dioxide(sulbactam)[J].J Org Chem,1982,47(17):3344-3345.
  • 10Moore BS,Carroll RD,Volkmann RA.Penicillanic acid 1,1-dioxide and its ester and intermediate[P].US:4420426,1979-05-05.

共引文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部